Meeting the counterfeit drug challenge
by Pacific Research Institute
Today, unapproved knock-off pharmaceuticals, gray market substitutes and counterfeits from South America come into the United States through Canada. This white paper by Peter J. Pitts, senior fellow in health care studies at the Pacific Research Institute and a senior vice president for health affairs at the public relations firm Manning Selvage and Lee, shows how the importation of these controlled substances highlights the Food and Drug Administration's concern that an increasing number of non-U.S. web sites are offering controlled substances to American consumers.
| Published: | 2005 |
| Format: | |
| Length: | 3 pages |
| Type: | White paper |
| Language: | English |
.
SPONSORED REPORTS
